RVL Pharmaceuticals plc Financing Cash Flow
RVL Pharmaceuticals plc reported Financing Cash Flow of -$5.32 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-08-14
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was -$460.00K.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was -$4.86M.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $1.40M, a 97.53% decline year-over-year.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $42.20M.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2022 was $41.78M.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2021 was -$135.33M, a 3775.45% decline from fiscal 2020.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2020 was $3.68M.
- RVL Pharmaceuticals plc net cash provided by (used in) financing activities for fiscal 2018 was $3.60M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$460.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$5.32M 10-Q · filed 2023-08-14 | -$3.92M derived: sum of 3 quarters · filed 2023-08-14 | $38.28M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | -$4.86M 10-Q · filed 2023-05-11 | -$3.46M derived: sum of 2 quarters · filed 2023-05-11 | $38.74M derived: sum of 3 quarters · filed 2023-05-11 | $37.76M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $43.60M derived: sum of 2 quarters · filed 2023-03-20 | $42.62M derived: sum of 3 quarters · filed 2023-08-14 | $41.78M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $42.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $41.22M derived: sum of 2 quarters · filed 2023-08-14 | $40.39M 10-Q · filed 2022-11-10 | $96.95M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | -$981.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.82M 10-Q · filed 2023-08-14 | $54.74M derived: sum of 3 quarters · filed 2023-08-14 | -$131.35M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$837.00K 10-Q · filed 2023-05-11 | $55.73M derived: sum of 2 quarters · filed 2023-05-11 | -$130.37M derived: sum of 3 quarters · filed 2023-05-11 | -$135.93M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $56.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$129.53M derived: sum of 2 quarters · filed 2023-03-20 | -$135.09M derived: sum of 3 quarters · filed 2023-03-20 | -$135.33M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$186.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$191.66M derived: sum of 2 quarters · filed 2022-11-10 | -$191.89M 10-Q · filed 2022-11-10 | -$194.97M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$5.79M 10-Q · filed 2022-08-11 | -$8.87M derived: sum of 3 quarters · filed 2022-08-11 | -$32.00M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$236.00K 10-Q · filed 2022-05-12 | -$3.31M derived: sum of 2 quarters · filed 2022-05-12 | -$26.44M derived: sum of 3 quarters · filed 2022-05-12 | -$27.53M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$26.21M derived: sum of 2 quarters · filed 2022-03-30 | -$27.29M derived: sum of 3 quarters · filed 2022-03-30 | $3.68M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$23.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$24.22M derived: sum of 2 quarters · filed 2021-11-15 | $6.76M 10-Q · filed 2021-11-15 | $4.88M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $29.89M 10-Q · filed 2021-08-16 | $28.01M derived: sum of 3 quarters · filed 2021-09-08 | $26.05M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2020-03-31 | $30.98M 10-Q · filed 2021-05-13 | $29.10M derived: sum of 2 quarters · filed 2021-09-08 | $27.13M derived: sum of 3 quarters · filed 2021-09-08 | $27.29M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$1.88M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$3.84M derived: sum of 2 quarters · filed 2021-09-08 | -$3.68M derived: sum of 3 quarters · filed 2021-09-08 | -$4.69M 8-K · filed 2021-09-08 | ||||
| 2019-09-30 | -$1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$1.80M derived: sum of 2 quarters · filed 2020-11-10 | -$2.81M 10-Q · filed 2020-11-10 | -$2.81M 10-Q · filed 2019-11-14 | $6.53M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$847.00K 10-Q · filed 2020-08-11 | -$846.58K 10-Q · filed 2019-08-08 | $8.49M derived: sum of 3 quarters · filed 2020-08-11 | $6.13M derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$1.01M 10-Q · filed 2020-05-12 | -$1.01M 10-Q · filed 2019-05-09 | $8.33M derived: sum of 2 quarters · filed 2020-05-12 | $5.96M derived: sum of 3 quarters · filed 2020-05-12 | $4.67M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $9.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $6.97M derived: sum of 2 quarters · filed 2020-03-19 | $5.68M derived: sum of 3 quarters · filed 2020-03-19 | $3.60M 10-K · filed 2020-03-19 | $3.60M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$3.66M derived: sum of 2 quarters · filed 2019-11-14 | -$5.73M 10-Q · filed 2019-11-14 | -$12.76M derived: sum of 4 quarters · filed 2019-12-20 | ||||
| 2018-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$3.37M 10-Q · filed 2019-08-08 | -$10.40M derived: sum of 3 quarters · filed 2019-12-20 | |||||
| 2018-03-31 | -$2.08M 10-Q · filed 2019-05-09 | -$9.10M derived: sum of 2 quarters · filed 2019-12-20 | ||||||
| 2017-12-31 | -$7.03M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | -$23.31M 8-K · filed 2019-12-20 | ||||||
| 2017-09-30 | -$16.29M 10-Q · filed 2018-11-08 |